Sprout AI(CSE: SPRT), a technologically focused, sustainable vertical farming company that has developed scalable, AI-controlled aeroponic cultivation habitats, will be providing cultivation services for JT Medical. JT Medical has announced that it is accepting memorandums of understanding (“MOUs”) from researchers looking to obtain high-quality, repeatable batch, plant-based medical products derived from regulated plants. The company noted that those plants may include cannabis, psilocybin mushroom and peyote. In the announcement, JT Medical said that SPRT provides self-contained habitats used in the process of producing its high-quality, repeatable batches. The habitats provide control of variables that impact crop duplication. JT Medical explained that the Sprout AI habitats will be operated via One System One Solution enterprise resource planning and compliance (“ERPc”) software. This process provides key information to researchers that enable them to track batches from seed, clone or tissue sample through to the final use or product. “Sprout AI habitats are used to ensure the replication of active medicinal plant ingredients as well as terpene, flavonoids and other desired components,” the company stated in the press release. “This enables both short-, mid- and long-term studies are derived from the ‘same’ product for medical research and efficacy reports.”
To view the full press release, visit https://ibn.fm/wPF8S
About Sprout AI Inc.
Sprout AI is a vertical farming technology company in the business of planning, designing, manufacturing and/or assembling sustainable and scalable AI-controlled vertical cultivation equipment for indoor vertical farming. The adaptive technology produces an environment with improved growing parameters and early detection of adverse conditions, resulting in consistent and repeatable crops with shorter cultivation cycles, independent of geographic climates. The self-contained multilevel rolling rack technology increases the cubic cultivation area while mitigating the risk of outside and cross-contaminants. For more information about the company, visit www.SproutAI.solutions.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.